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Background: Cold storage of arteries for reconstructive and bypass surgery may result in injury of endothelial cells which
may promote low perfusion and graft vasculopathy.
Methods:A recently developedN-acetyl histidine-buffered, potassium-chloride enriched, and amino acid-fortified vascular
storage solution augmented with iron chelators deferoxamine (100 mol/L) and LK 614 (20 mol/L) was studied in
the rat superior mesenteric artery and aorta with respect to: (1) potassium-induced vessel tone, (2) endothelium-
dependent and -independent relaxation, and (3) endothelial nitric oxide synthase (eNOS) protein expression over 4-days
cold storage (4°C).This solution was compared with traditional storage solutions, histidine-tryptophan-ketoglutarate
(HTK) and physiological saline solution (PSS).
Results: Vessels stored for 4 days in the new solution were significantly better protected than those stored in traditional
HTK or PSS. The protective effects comprised: (1) vessel tone development after stimulation with potassium-chloride
solution, (2) endothelium-dependent and -independent vessel relaxation, and (3) eNOS expression. With iron chelators
(deferoxamine 100 M, LK 614 20 M) present in the storage solution, endothelium-dependent relaxations (eNOS-
dependent and KCa-channel-dependent) were fully maintained after 96 hours of cold storage. Endothelial cell structure
was significantly better maintained after 96 hours in the new solution than in HTK or PSS solutions. Already, 2 hours
of cold storage in HTK resulted in a significant loss of structurally intact endothelium. The structural changes correlated
significantly with the diminished vessel relaxation capacity. Furthermore, tissue reductive capacity was only preserved
after 96 hours storage if the new solution was used.
Conclusion: The new storage solution is superior to traditional HTK and PSS cold storage with respect to: (1)
preservation of vessel structure and function; (2) the presence of iron chelators significantly improved protection of
endothelial function; and (3) the new solution permits cold vessel storage for a minimum of 4 days with full maintenance
of endothelial function and its coupling to smooth muscle. ( J Vasc Surg 2009;50:397-406.)Vascular allografts are an important therapeutic option
for surgical management of infrarenal aortic prosthetic graft
infection.1 For smaller vessels (6 mm diameter), synthetic
grafts have proved to be unsatisfactory and the attention is
therefore directed toward the use of allografts.2 Freshly
isolated vessels and cryopreserved grafts have been used
with similar clinical outcomes.1,3-6 Despite their frequent
application, current storage protocols need further im-
provement, in particular with respect to maintenance of
endothelial cell function,7-9 because impaired endothelial
function may result in low perfusion after revascularization
and promote postoperative graft vasculopathy.8,10
Cold storage (0-4°C) decreases tissue metabolism, and
thus permits a better maintenance of cell energy homeosta-
sis by anaerobic metabolism than warm storage. However,
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doi:10.1016/j.jvs.2009.04.064cold storage and subsequent re-warming may also activate
specific injury processes, eg, production of reactive oxygen
species triggered by a cold-induced rise of the cellular
chelatable iron11,12 which may deteriorate endothelial
function.13,14 A 24-48 hour period of successful endothe-
lium and microvessel preservation during cold storage has
been reported.15-17 It seems highly desirable to extend this
period and improve the availability of donor tissues. A
recent experimental study reported substantial progress
with respect to long-term storage of pig aortic segments
over 3 weeks.18 Based on the analysis of endothelial mito-
chondrial membrane potential and adhesion of platelets to
endothelial cells, grafts were successfully stored in an N-
acetyl histidine-buffered, potassium-chloride enriched, and
amino acid-fortified storage solution augmented with iron
chelators. This formula may help to avoid toxic side effects
of histidine19 and simultaneously utilize the cytoprotective
effects of amino acids, eg, glycine and alanine in prevention
of hypoxic injury.18 The iron chelators may protect against
iron catalyzed Fenton-type reactions during cold storage.12
The specific question addressed in this study was
whether the previously developed new storage solution
(solution 8 augmented with deferoxamine and LK 614)18
permits a prolonged storage of arteries with full mainte-
nance of endothelium-dependent vessel relaxation and en-
dothelial nitric oxide synthase (eNOS) expression which is
crucial for vessel function after vessel reconstructive and
bypass surgery. The results clearly show that this is feasible.
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The experimental project conforming to National In-
stitutes of Health (NIH) guidelines was approved by the
German local authorities (permission 24D-9168.24-1-
2006-23). Vessels isolated from male Wistar rats (Charles
River Laboratories, Sulzfeld, Germany) anesthetized with
urethane (1 mL/100 g i.p.) were flushed with physiological
saline solution (PSS), histidine-tryptophan-ketoglutarate
(HTK) solution, or the newly developed preservation solu-
tion (solution 8, Table I).18 To explore potentially detri-
mental effects of a high potassium concentration,20 we also
tested in a modified solution with the potassium concen-
tration reduced and the sodium increased (solution 9,
Table I).18 In a subset of experiments, solution 8 and HTK
were augmented with the iron chelators deferoxamine (100
mol/L) and LK 614 (20 or 10 mol/L). After clearing
off surrounding adipose tissue, the vessels were stored in
the identical solution (4°C) for up to 96 hours. Then vessel
segments were transferred to PSS solution and subjected to
function testing 30 minutes after warming to 37°C.
Vessel function analysis. Mesenteric vessel function
was measured with a Mulvany myograph (Power Lab/400,
AD-Instruments, Spechbach, Germany), connected to a
personal computer (PC) by interface Model 410A (Danish
Myo Technologies, Aarhus, Denmark). Chart v4.1.2 soft-
ware (AD Instruments, Spechbach, Germany) permitted
data acquisition. Arteries (outer diameter 200-260 m, cut
2 mm in width) were mounted to a PC-linked force trans-
ducer located in an organ chamber filled with PSS (equili-
brated with 5/95% CO2/O2, pH 7.4, 37°C). Vessel rings
Table I. Composition of solutions used for storage of
mesenteric arteries
Solution 8 Solution 9 HTK PSS
-Ketoglutarate 2 2 1 —
Aspartate 5 5 — —
Histidine — — 198 —
N-Acetylhistidine 30 30 — —
Glycine 10 10 — —
Alanine 5 5 — —
Tryptophan 2 2 2 —
Sucrose 20 20 — —
Glucose 10 10 — 5.5
Mannitol — — 30 —
Cl 103.1 103.1 50 128.7
H2PO4
 1 1 — 1.18
SO4
2 — — — 1.17
HCO3
 — — — 25
Na 16 104 15 144
K 93 5 10 5.9
Mg2 8 8 4 1.17
Ca2 0.05 0.05 0.015 2.5
EDTA — — — 0.027
pH 7.0 7.0 7.2 N.D.
Osmolarity 305.15 305.15 310 320
Concentrations are given in mmol/L, osmolarity is given in mosm/L.
HTK, Histidine-tryptophan-ketoglutarate; PSS, physiological saline
solution.were stretched with a resting tension equivalent to anintraluminal pressure of 100 mm Hg. Maximum contrac-
tion was induced with potassium enriched solution (KPSS),
containing (mmol/L) 123.7 KCl, 1.17 MgSO4, 1.18
KH2PO4, 25 NaHCO3, 5.5 glucose, 0.027 EDTA and 2.5
CaCl2. After preconstriction with 7.5 mol/L norepineph-
rine endothelium-dependent vasorelaxation was determined
using acetylcholine (109-105.5 M) and endothelium-
independent relaxation using sodium-nitroprusside (109-
104 M). Endothelial nitric oxide production was inhibited
using L-N-monomethyl-arginine (L-NMMA, 100 mol/
L), cyclooxygenase with indomethacin (3 mol/L) or
diclofenac (10 mol/L), Ca-dependent potassium chan-
nels (KCa) with charybdotoxin (50 nmol/L; large conduc-
tance KCa) and apamin (50 nmol/L; intermediate conduc-
tance KCa).
Protein expression. Vessels stored for 2 and 96 hours
in either solution 8 augmented with deferoxamine (100
mol/L) and LK 614 (20mol/L), HTK, or PSS solution
(at 4°C) were studied without re-warming before protein
isolation by chloroform/methanol precipitation. Protein
content was determined by the amidoblack-method.21 For
Western blotting, 2.5 g of total protein was used for each
lane, separated by 10% sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE) and transferred to
nitrocellulose membranes (Amersham, Munich, Germany)
by electro blotting. Protein expressions were assessed using
antibodies against eNOS (BD Pharmingen, Heidelberg,
Germany),  actin, and tubulin (Sigma, Taufkirchen, Ger-
many). A modified custom-made ECL (Hybond ECL ni-
trocellulose membrane; Amersham Life Science, Arlington
Heights, Ill) Western blotting detection method was used.
Horseradish peroxidase anti-rabbit IgG goat anti-mouse
IgG was obtained from Dianova (Hamburg, Germany).
Blots were quantified using Image Gauge on an LAS 3000
analyzer (Fujifilm Life Science, Stamford, Conn).
Tissue reductive capacity. Rat aorta (n  6) was
stored in the different solutions for 96 hours and then
gently warmed to 37°C within 1 hour. Thirty minutes later,
resazurin (Alamar Blue) was added at a final concentration
of 40 M. The reduction of resazurin was assessed, as
described before,19 to measure reductive capacity which
mainly reflects mitochondrial integrity and metabolism.
Lactate dehydrogenase release. Extracellular, ie, re-
leased lactate dehydrogenase (LDH) activity was measured
in aliquots of the storage solution of rat aorta (n 6) using
standard procedures (Department of Clinical Chemistry,
University Hospital Dresden). The LDH activity normal-
ized to mg protein was expressed in mol s1 l1.
Endothelial structure. Rat mesenteric vessels stored
for 2 and 96 hours at 4°C were studied. At the end of the
storage period, the vessels underwent immediate fixation
with glutaraldehyde (25%) and sodium cacodylate buffer
(0.1 M) at a ratio 1:9 (vol/vol) without re-warming. After
being washed in 0.1 M sodium cacodylate buffer (2 hours,
4°C), washed again, dehydrated in ethanol, and embedded
in Epon 812, polymerization was carried out at 60°C.
Specimens were viewed at 80 kV using an EM 906 micro-
scope (Zeiss, Oberkochen, Germany). For semiquantitative
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ferent sections per vessel) were used and estimated under a
conventional light microscope (Olympus BX60; Olympus,
Hamburg, Germany) with the investigator blinded to the
experimental protocol. The scoring scheme is summarized
in Table II.
Data analysis. Dose-response curves of relaxations
were quantified by fitting the sigmoidal dose-response
function R(x) to the experimental data
Rx  Rmax 1  exp  x  EC50 R ,
where x represents the logarithmic value of the applied
dose. The resulting fit parameters Rmax, EC50, and R
were obtained with Bayesian data analysis and characterize
each group of vessels. Rmax reflects the maximum relax-
ation value and EC50 gives the concentration where half
maximal relaxation is reached. The parameter R specifies
the slope of the transition around EC50.
Statistics. Data are presented as mean values and
their SEMs. Normal distribution was tested using the
Kolmogorov-Smirnov test with modification after the Lil-
liefors test. Homogeneity of variances was assessed accord-
ing to the Levene test. Differences of failure rates (vessels
not responding to potassium stimulus) between groups
were assessed using 	2-statistics. Inter-group differences to
stimuli were tested using one-way analysis of variance with
post-hoc multiple comparisons after the Bonferroni correc-
tion. Regression analysis was performed according to the
Spearman rank correlation. A P-value of .05 or less (two-
sided) was taken to indicate a significant difference. Data
analysis was performed using the SPSS program v15.0
(SPSS Inc, Chicago, Ill).
RESULTS
Effects of cold storage on potassium-induced vessel
tone. Within 2 hours of isolation (control measurements),
all mesenteric vessels studied (n  116) responded to the
KPSS developing significant vessel tone between 4.4 and
5.7 mN/mm (Fig 1). There was no significant difference
between storage protocols after 2 hours. However, after 96
hours of storage at 4°C, major inter-group differences were
evident with respect to vessel tone generation in response
to KPSS (Table III). Whereas after storage in solution 8
with and without iron chelators, less than 10% of the vessels
failed (no tone development during KPSS), the fraction of
failing vessels was significantly increased after storage in
Table II. Scoring of endothelial cell injury
Score Description
I Well preserved endothelium
II Intact endothelial layer with vacuole formation and edema
III Endothelium detached in large fractions
IV Complete denudation of the endothelium with single
remaining cells
For illustration of injury please refer to Fig 7.HTK solution with and without iron chelators (63% and38%). Storage in solution 9 gave similar results as storage in
HTK solution. Thus, potassium-enriched solution (solu-
tion 8) protected better than storage at a low-potassium
concentration (solution 9, HTK, Table I). All vessels stored
in PSS solution for 96 hours failed to develop tone upon
stimulation with KPSS. The superior preservation of vessels
stored in solution 8 was highly significant vs the other
storage solutions (Table III).
After 96 hours of cold storage in HTK, KPSS-stimulated
wall tension was reduced as compared with 96 hours of
storage in solution 8 (Fig 1). Addition of iron chelators did
not significantly affect tension development in response to
KPSS. Tension development after exposure to norepineph-
rine was generally 90-110% of that measured in the pres-
ence of KPSS.
Effects of different solutions and iron chelators on
endothelium-dependent relaxation. We next explored
the effects of solution 8 and of iron chelators on endothelium-
dependent (acetylcholine, [ACH]) and endothelium-
independent (sodium nitroprusside [SNP]) relaxations.
Vessel relaxation in response to ACH was well preserved
after 2 hours of cold storage in solution 8. However,
without addition of iron chelators, ACH-evoked relaxation
was significantly reduced after 96 hours of storage in solu-
tion 8 (from 92
 1 to 67
 10%, P .021). This effect was
prevented by addition of iron chelators. After 2 hours of
storage in solution 9, vessel relaxation by ACH was reduced
(76
 9%, P .028 least-significant difference [LSD]-test).
No significant differences resulted for SNP-induced relax-
ations with respect to storage solutions 8 vs 9 or with
respect to the presence of iron chelators (2 and 96 hours).
Full concentration-response curves for ACH and SNP
are shown in Fig 2 for vessels stored over 2 and 96 hours in
either solution 8 (without and with augmentation with
deferoxamine and LK 614), HTK, or PSS. This figure
contains only data from vessels that developed tension after
exposure to high potassium-chloride, ie, when failing vessel
segments (Table III) were excluded from analysis. Then,
concentration-response curves did not differ significantly
from each other. However, if all vessels studied in the
different storage groups were included in the analysis, then
maximal relaxation toward ACH was significantly blunted
in vessels stored 96 hours in cold HTK (Fig 3). The fact
that function of vessels stored in HTK fell into two groups
(preservation failures and successes) probably reflects the
time course of the development of failure in this group
(around 96 hours with some biologic variability). All vessels
stored for 96 hours in PSS neither exhibited vessel tone
development when exposed to KPSS or norepinephrine nor
did the vessels show any relaxation toward ACH or SNP
(P  .0001 vs all other groups). In vessel segments stored
48 hours in PSS, the endothelium-dependent relaxation
was already abolished90%, whereas direct smooth muscle
relaxation was still present at this time point (data not
shown).
Maintenance of NO- and EDHF-mediated responses.
To quantitatively assess the potential of endothelium-
dependent relaxation in vessels stored in solution 8 aug-
rs; H
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(NO)-dependent and the endothelium-derived hyperpo-
larizing factor (EDHF)-dependent components of vessel
relaxation were quantified (Fig 4). L-NMMA shifted the
concentration-response curve of ACH significantly to the
right. In presence of L-NMMA addition of apamin plus
charybdotoxin completely blunted the effects of ACH.
Blockers of cyclo-oxygenases (indomethacin n  12 or
diclofenac n  8) did not have any significant effect on the
relaxation toward ACH (data not shown). Blockage of
KCa-channels by apamin plus charybdotoxin reduced the
maximum of the concentration-response curve of SNP
(P .05). All effects were similar after 2 and 96 hours cold
storage.
Effects on protein expression. Fig 5 depicts expres-
Fig 1. Vessel tension development after stimulation wit
shown for vessels stored for 2 (black bars) and 96 hour
responded to potassium exposure (potassium enriched s
bars represent all vessels studied. The variations in solutio
differences in the addition of iron chelators LK 614 (
concentrations in M. P  .001, *P  .0001 vs the re
solution; h, hours.
Table III. Functioning vessels after 2 and 96 hours storag
Functioning
vessels after
96h/2h Sol. 8 Sol. 8
Solution 8 8/8 —
Solution 8  LK(20) 5/6 N.S.
Solution 8  D(100)  LK(10) 9/9 N.S.
Solution 8  D(100)  LK(20) 30/33 N.S.
Solution 9 6/10 P  .05
HTK 13/21 P  .05
HTK  D(100)  LK(20) 3/8 P  .01
PSS 0/21 P  .001 P
Test stimulus was KPSS. Functioning vessels are defined as specimen develo
of LK 614 (LK) and deferoxamine (D) in mol/L. P-Values indicate sign
LK(20)  D(100) did not differ significantly. N.S., Not significant; h, hou
KPSS, potassium enriched solution.sion of eNOS, tubulin, and -actin proteins in mesentericartery given as the ratio of measurements after 2 and 96
hours cold storage. Whereas protein expression was well
preserved if storage was done in solution 8 augmented with
iron chelators or HTK, it was blunted after 96 hours
storage in PSS (protein loss 70% to 83%).
Effects on endothelial cell structure. Fig 6 depicts
different degrees of endothelial damage as assessed by light
and electron microscopy in mesenteric arteries. Criteria for
damage scoring are given in Table II and illustrated in
Fig 7. Endothelial cell structure was well maintained after 2
hours of cold storage in solution 8, augmented with defer-
oxamine and LK 614, or PSS. However, injury was evident
in vessels stored in traditional HTK solution even after 2
hours (P  .006). After 96 hours of storage in PSS,
endothelial cell structure was severely deteriorated (P 
h potassium-chloride solution (123.7 mM). Results are
n and hatched bars). Open bars represent vessels which
n [KPSS]) with tone development (Table III), hatched
nd histidine-tryptophan-ketoglutarate (HTK) designate
r deferoxamine (D). Numbers in parenthesis indicate
ive condition using solution 8. PSS, Physiological saline
different solutions
Significance vs
K(20) Sol. 8  LK(10)  D(100) Sol. 8  LK(20)  D(100)
. N.S. N.S.
N.S. N.S.
. — N.S.
. N.S. —
. P  .05 P  .05
. P  .05 P  .01
. P  .01 P  .001
001 P  .001 P  .001
one during exposure to KPSS. Numbers in parenthesis give concentrations
e levels for inter-group comparisons. Vessels stored in HTK and HTK 
TK, histidine-tryptophan-ketoglutarate; PSS, physiological saline solution;h hig
s (ope
olutio
n 8 a
LK) o
specte in
 L
N.S
—
N.S
N.S
N.S
N.S
N.S
 .0
ping t
ificanc.008), whereas endothelial structure was preserved in ves-
re sh
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After 96 hours of storage in HTK, endothelial cells exhib-
ited a degree of damage similar to that after 2 hours of HTK
storage. Endothelial injury score correlated negatively with
acetylcholine induced vessel relaxation (r0.36, n 36,
P .03). Thus, the structural changes may in part account
for the diminished vessel relaxation.
Protective effects in rat aortic tissue. To assess
whether the protective effects seen in mesenteric artery
segments may be extrapolated to large conduit arteries,
further measurements were performed in rat aorta. Expres-
sion of eNOS, tubulin, and -actin after storage in different
solutions was similar to that found in mesenteric arteries
(results not shown). LDH activity released from aortic
rings was similar for all storage solutions after 2 hours at
4°C (5.9 
 2.2 mol s1 l1 per mg protein). However,
after 96 hours of cold storage released-LDH activity was
17.8 
 5.2 (P  0.05 vs. control), 13.9 
 2.6 and 7.0 

1.3 mol s1 l1 per mg protein, respectively, for HTK,
PSS, and solution 8 augmented with iron chelators. Resa-
Fig 2. Relaxation properties of vessel segments respond
tone development (note that functioning vessels diffe
stimulation with acetylcholine (ACH) and Na-nitropruss
and 96 hours (lower panel) storage. Storage conditions w
LK 614 (20 M), respectively, histidine-tryptophan-k
Curves as fit to the function R(x) are shown. Experim
number of vessels included. Data for all vessels studied azurin reduction was significantly higher (P .001) after 96hours storage in solution 8 augmented with iron chelators
(108 
 13%, ie, similar to unstored controls) than after
storage in PSS (48 
 13%) or HTK (41 
 6 %). Already
after 2 hours of cold storage in HTK, reductive capacity
declined (Fig 8).
DISCUSSION
The major finding of the present study is that rat
mesenteric arteries and aorta stored at 4°C in the new
vascular preservation solution 8, augmented with iron ch-
elators deferoxamine and LK 614, were significantly better
protected with respect to function and structure than vessels
stored in traditional HTK or PSS. The protective effects of this
new solution were objectified by: (1) vessel tone development
after stimulation with KPSS, (2) endothelium-dependent ves-
sel relaxation, (3) endothelium-independent vessel relaxation,
(4) maintenance of protein expression, (5) tissue reductive
capacity, and (6) maintenance of endothelial cell structure. In
contrast, vessels stored in HTK for only 2 hours exhibited a
significant loss of structurally intact endothelium and tissue
o the potassium enriched solution (KPSS) stimulus with
etween groups, Table III). Shown are relaxations to
odium nitroprusside [SNP]) after 2 hours (upper panel)
olution 8 without and with deferoxamine (100M) plus
tarate (HTK), or physiological saline solution (PSS).
data is shown as mean 
 SEM. Numbers indicate the
own in Fig 3.ing t
red b
ide (s
ere s
etoglu
entalreductive capacity declined. Most notably, after 96 hours
.0001 PSS vs HTK () and PSS vs solution 8 augmented with iron chelators (*). h, Hours.
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[SNP]) after 2 hours (upper panels) and 96 hours (lower panels) storage in solution 8 augmented with deferoxamine
(100 M) plus LK 614 (20 M). Concentration-effect curves are shown as fit to the function R(x) for control
conditions (continuous line), after application of L-N-monomethyl-arginine (L-NMMA) (broken line), and after
application of L-NMMA plus apamin plus charybdotoxin (dotted line). *Indicates a significant difference of maximalFig 3. Relaxation properties of all vessel segments studied irrespective of tone development during potassium
enriched solution (KPSS) stimulus (Table III). Shown are relaxations to stimulation with acetylcholine (ACH) and
Na-nitroprusside (sodium nitroprusside [SNP]) after 96 hours storage. Number of experiments is indicated by the
number next to respective curve. Left panel: P  .004 solution 8 augmented with iron chelators vs histidine-
tryptophan-ketoglutarate (HTK), *P .0001 physiological saline solution (PSS) vs other solutions. Right panel: Prelaxation, indicates a significant difference of EC50. Numbers indicate the number of vessels tested.
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structural injuries were evident.
Differentiation of endothelium-dependent vessel
relaxation. The contributions of NO and KCa-channels
were assessed using validated pharmacological inhibitor
protocols.22,23 L-NMMA is a potent inhibitor of eNOS in
the concentration used. Because block of cyclooxygenase
by indomethacin and diclofenac did not significantly re-
duce the relaxation toward acetylcholine, the remaining
relaxation of rat mesenteric artery in the presence of
L-NMMA is most likely mediated via activation of KCa-
channels.24 This is supported by the complete elimina-
tion of acetylcholine-induced relaxation after combined
block of intermediate and large (charybdotoxin) and
small (apamin) conductance KCa-channels (Fig 4). In
addition to smooth muscle, endothelial cells are also
equipped with KCa-channels.
25 Functional involvement
of endothelial KCa-channels in NO release has been
demonstrated in rat mesenteric artery.26 Thus, block of
endothelial KCa-channels may have contributed to blunt-
ing the relaxation effect of acetylcholine. However,
Fig 5. Protein expression of endothelial nitric oxide syn
storage. Storage conditions were solution 8 augment
histidine-tryptophan-ketoglutarate (HTK) or physiolog
under (A) for 2.5 mg total protein per lane. Mean values
under (B). Data is expressed as the ratio of measureme
groups. h, Hours.apamin and charybdotoxin also blocked smooth muscleKCa-channels (Fig 4) evidenced by the reduced relax-
ation after Na-nitroprusside stimulation. Vasorelaxation
toward acetylcholine after eNOS inhibition (L-NMMA)
and cyclooxygenase inhibition (which did not play a role
in the model used) is interpreted as EDHF-mediated
relaxation.22,23
The expression of eNOS as a marker enzyme of
endothelium-dependent relaxation was reduced after ex-
tended storage in PSS in relation to other proteins
(tubulin, -actin) (Fig 5). In agreement with this result is
the missing vessel tone development after KPSS exposure (Fig
1), the missing effects of acetylcholine and Na-nitroprusside
on vessel tone (Fig 3), reduced reductive capacity (Fig 8) and
the severe endothelial cell injury (Fig 6) after 48 hours of cold
storage in PSS. This generalized vessel injury is preceded by an
endothelium specific injury of vessel relaxation until 48 hours.
Vascular storage injury and chelatable iron. A re-
cent study15 has addressed endothelial structural changes
of rat abdominal aorta after 24 hours of storage in Univer-
sity of Wisconsin (UW), Collins, and Euro-Collins solu-
(eNOS), tubulin and -actin after 2 and 96 hours cold
ith deferoxamine (100 M) plus LK 614 (20 M),
aline solution (PSS). Typical Western blots are shown
(solution 8), 10 (HTK), and 5 vessels (PSS) are shown
erformed after 2 and 96 hours. *P  .01 PSS vs otherthase
ed w
ical s
of 13
nts ptions. Endothelial cell structure was maintained after 24
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storage resulted in structural endothelial cell injury early
during cold exposure (Fig 6). However, when re-warmed
after 2 hours of cold exposure in HTK, vessel relaxation
toward acetylcholine and Na-nitroprusside was still present
in a significant fraction of the vessels (Figs 2 and 3) if
KPSS-induced vessel tone development was maintained
(Table III). A loss of rat coronary resistance vessel dilatory
capacity was also evident after 8 hours of cold storage in
HTK solution.14 This impairment was ameliorated by aug-
menting HTK with iron chelators. Similarly, the endothe-
lial cell injury in cold-stored porcine aorta was inhibited by
the iron chelators deferoxamine and LK 614,18 and in the
present study the protective effect of solution 8 is aug-
mented by the presence of the same iron chelators. This
confirms in vitro data (cultured endothelial cells) that che-
latable iron is an important factor causally involved in
cold-induced endothelial injury11,27-29 and adds further
evidence that this concept is valid for clinically-relevant
storage conditions.
Protective principles of the new vascular preserva-
tion solution. Part of the protection by the new vascular
preservation solution is provided by the iron chelators.
Deferoxamine is a strong hexadentate iron chelator that has
been in clinical use for the treatment of hemochromatosis
for decades. Because it has the disadvantage of poor
membrane-permeability, it is supplemented with the new
chelator LK 614, a small aromatic hydroxamic acid de-
rivative, that is supposed to provide the primary protec-
tion against the adverse effects of intracellular chelatable
iron during cold preservation.18
Already in the absence of iron chelators, solution 8
Fig 6. Endothelial injury scores after 2 and 96 hours co
to Fig 5. Scoring criteria are shown in Table II and exemp
with iron chelators and physiological saline solution (P
‡significantly different vs solution 8 at 96 hours. Vess
respectively, and 10 for all other conditions. h, Hours.provided superior protection when compared to HTK andPSS. Solutions 8 and 9 are N-acetyl histidine-buffered; this
buffer has the advantage over histidine (the buffer of HTK
solution) that it does not share the toxic side effects of
histidine19 and over bicarbonate (the buffer in PSS) that its
pK value of 7.2 (at room temperature) is better suited to
prevent (severe) acidosis under hypothermic conditions.
Also, it does not require the balance with CO2. In addition,
10 mM glucose provide substrate for the highly glycolytic
endothelial cells30,31 and cytoprotective amino acids, espe-
cially glycine and alanine, provide protection against hy-
poxic injury.32-34 Furthermore, the moderately acidic pH
has proven advantageous in porcine aortic segments.18 It
was beyond the scope of the current study to evaluate these
single components individually.
Potassium chloride-enriched solution 8 offers solid
protection of arterial vessels during extended periods of
cold storage (Figs 1-6, Fig 8, Table III). Solution 9, which
differs from solution 8 only by the concentrations of potas-
sium and sodium, did not protect as well. This is in agree-
ment with results recently found in pig aorta,18 and it is
remarkable because potassium-rich solutions are widely
regarded as toxic for the endothelium (for a general discus-
sion on this point see Wille et al18). In particular, it has
previously been concluded that high potassium storage
solutions may be detrimental for EDHF-mediated vasore-
laxation in pulmonary microvessels20 and coronary vessel
preparations.35,36 Our results with apamin and charybdo-
toxin argue against a generalization of this notion and
suggest that EDHF-mediated relaxation is well preserved in
the new solution 8.
Study limitations. As an experimental model we have
chosen the rat aorta and mesenteric artery, because these
rage. Storage conditions were those given in the legend
in Fig 7. *Significantly different vs solution 8 augmented
at 2 hours, †significantly different vs PSS at 2 hours,
died were 14 and 13 for 2 and 96 hours solution 8,ld sto
lified
SS)
els stuvessels have been well characterized. In particular, the
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relaxation have been studied in detail in rat mesenteric
artery,26,37 which shows similar mechanisms of relaxation
as the human vessel.38 Furthermore, vessels taken from
standard laboratory animals can be studied in a well stan-
dardized manner, unaffected by pathologic processes as
they may occur in tissues obtained from humans. Nonethe-
less, future studies using human vessels will be required to
extend the promising results of the present study to the
clinical arena.
Future potential of improved cold storage. Because
of appreciable clinical importance, the benefits and disad-
vantages of specific storage protocols need to be studied in
more detail and be comprehensively documented. Current
Fig 7. Micrographs illustrating the injury scores. Injury grade IV
resulted in a complete loss of endothelium (not shown).clinical experience has resulted in various vessel storageprotocols, which may rather reflect experiences of different
surgical teams than systematic research. Systematic re-
search, however, is required to improve protocols for ex-
tended vessel storage periods. This will permit to: (1)
extend storage protocols for banking of grafts for later
transplantation, (2) separate the time of vessel explantation
and bypass surgery, (3) store vessel segments for later
revision surgery, and (4) improve functional and structural
quality of the graft.
In conclusion, the present study provides compelling
evidence that the N-acetyl histidine-buffered, potassium
chloride-enriched, amino acid fortified storage solution 8
allows superior preservation of arteries over several days of
cold storage. Augmentation with the iron chelators defer-
oxamine and LK 614 fully maintains the endothelium-
dependent vessel function over at least 4 days.
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